Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-19T22:12:07.093Z Has data issue: false hasContentIssue false

21 - Liver Disease in Immunodeficiencies

from SECTION III - HEPATITIS AND IMMUNE DISORDERS

Published online by Cambridge University Press:  18 December 2009

Nedim Hadžić M.D.
Affiliation:
Senior Lecturer, Institute for Liver Studies, King's College London School of Medicine at King's College Hospital, London, England; Consultant in Paediatric Hepatology, Department of Children's Health, King's College Hospital, London, England
Frederick J. Suchy
Affiliation:
Mount Sinai School of Medicine, New York
Ronald J. Sokol
Affiliation:
University of Colorado, Denver
William F. Balistreri
Affiliation:
University of Cincinnati
Get access

Summary

Man and microbes are committed to a perennial evolutionary conflict in which the human immune system represents a powerful tool of protection against invasion. The liver plays an important role in the immune defense because of its central position adjacent to the gastrointestinal tract, representing the first line of defense against ingested pathogens and various antigens from food.

There are two types of immune response innate and adaptive. Innate immunity represents the first line of immune defense in which cells such as phagocytes, natural killer (NK) cells, and NK T cells recognize highly conserved antigens from the invading microorganisms and provide a prompt nonspecific inflammatory response. The principal intrahepatic defenders are Kupffer cells – resident macrophages, strongly supported by the action of NK cells, previously also known as Pit cells, which represent approximately 50% of the lymphocyte pool in a healthy liver. In contrast, the adaptive immune system is more phylogenetically advanced and includes more highly specialized cells such as T and B lymphocytes, produced and differentiated in the lymphoid organs. On stimulation, these cells undergo sophisticated processes of immune diversification enabling them to mount specific immune responses to different invading antigens from the environment. These events are much slower and involve mechanisms such as cell-to-cell interaction, proliferation of B cells, production of antibodies and cytokines, and activation of effector cytotoxic cells.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mackay, I R. Hepatoimmunology: a perspective. Immunol Cell Biol 2002;80:36–44.CrossRefGoogle ScholarPubMed
Crispe, I N, Dao, T, Klugewitz, K. The liver as a site of T-cell apoptosis: graveyard, or killing field?Immunol Rev 2000;174:47–62.CrossRefGoogle ScholarPubMed
Weiler-Normann, C, Rehermann, B. The liver as an immunological organ. J Gastroenterol Hepatol 2004;19:S279–83.CrossRefGoogle Scholar
Rolando, N, Wade, J, Davalos, M. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32:734–9.CrossRefGoogle ScholarPubMed
Tilg, H, Wilmer, A, Vogel, W. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264–74.CrossRefGoogle ScholarPubMed
Izumi, S, Hughes, R D, Langley, P G. Extent of the acute phase response in fulminant hepatic failure. Gut 1994;35:982–6.CrossRefGoogle ScholarPubMed
Notarangelo, L, Casanova, J L, Fischer, A. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 2004;114:677–87.CrossRefGoogle ScholarPubMed
Jones, A M, Gaspar, H B. Immunogenetics: changing the face of immunodeficiency. J Clin Pathol 2000;53:60–5.CrossRefGoogle ScholarPubMed
Rosen, F S, Cooper, M D, Wedgwood, R J P. The primary immunodeficiencies. N Engl J Med 1995;333:431–40.CrossRefGoogle ScholarPubMed
Hammer, S M. Management of newly diagnosed HIV infection. N Engl J Med 2005;353:1702–10.CrossRefGoogle ScholarPubMed
Durandy, A, Honjo, T. Human genetic defects in class-switch recombination (hyper-IgM syndromes). Curr Opin Immunol 2001;13:543–8.CrossRefGoogle Scholar
Rodrigues, F, Davies, E D, Harrison, P. Liver disease in primary immunodeficiencies. J Pediatr 2004;145:333–9.CrossRefGoogle ScholarPubMed
Record, C O, Shilkin, K B, Eddleston, ALWF, Williams, R. Intrahepatic sclerosing cholangitis associated with a familial immunodeficiency syndrome. Lancet 1973;ii:18–20.CrossRefGoogle Scholar
Thomas, I T, Ochs, H D, Wedgwood, R J. Liver disease and immunodeficiency syndromes [letter]. Lancet 1974;ii:311.CrossRefGoogle Scholar
Naveh, Y, Mendelsohn, H, Spira, G. Primary sclerosing cholangitis associated with immunodeficiency. Am J Dis Child 1983;137:114–17.Google ScholarPubMed
Davis, J J, Heyman, M B, Ferrell, L. Sclerosing cholangitis associated with chronic cryptosporidiosis in a child with a congenital immunodeficiency disorder. Am J Gastroenterol 1987;82:1196–202.Google Scholar
Hayward, A R, Levy, J, Facchetti, F. Cholangiopathy and tumours of the pancreas, liver and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997;158:977–83.Google ScholarPubMed
McLauchlin, J, Amar, C F L, Pedraza-Diaz, S. Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficiencies. Pediatr Inf Dis J 2003;22:329–34.CrossRefGoogle ScholarPubMed
Chen, X M, Keithly, J S, Paya, C V, LaRusso, N F. Cryptosporidiosis. N Engl J Med 2002;346:1723–31.CrossRefGoogle ScholarPubMed
Mead, J R, Arrowood, M J, Sidwell, R W, Healey, M C. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis 1991;163:1297–304.CrossRefGoogle ScholarPubMed
Stephens, J, Cosyns, M, Jones, M, Hayward, A. Liver and bile duct pathology following Cryptosporidium parvum infection of the immunodeficient mice. Hepatology 1999;30:27–35.CrossRefGoogle ScholarPubMed
Chen, X M, Levine, S A, Tietz, P. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 1998;28:906–13.CrossRefGoogle ScholarPubMed
Petersen, J. Cryptosporidiosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1992;152:2497–9.Google Scholar
Chen, X M, LaRusso, N F. Cryptosporidiosis and the pathogenesis of AIDS cholangiopathy. Semin Liver Dis 2002;22:277–89.CrossRefGoogle ScholarPubMed
Kline, T J, Las Morenas, T, O'Brien, M. Squamous metaplasia of extrahepatic biliary system in an AIDS patient with cryptosporidia and cholangitis. Dig Dis Sci 1993;38:960–2.CrossRefGoogle Scholar
Cello, J P. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 1989;86:539–46.CrossRefGoogle Scholar
Gerber, D A, Green, M, Jaffe, R, Greenberg, D. Cryptosporidial infections after solid organ transplantation in children. Pediatr Transplant 2000;4:50–5.CrossRefGoogle ScholarPubMed
Campos, M, Jouzdani, E, Sempoux, C. Sclerosing cholangitis associated to cryptosporidiosis in liver-transplanted children. Eur J Pediatr 2000;159:113–15.CrossRefGoogle ScholarPubMed
Hadzic, N, Pagliuca, A, Rela, M. Correction of the hyper IgM-syndrome after liver and bone marrow transplantation. N Engl J Med 2000;342:320–4.CrossRefGoogle ScholarPubMed
Winkelstein, J A, Marino, M C, Ochs, H. The X-linked hyper-IgM syndrome. Clinical and immunological features of 79 patients. Medicine 2003;82:373–84.CrossRefGoogle Scholar
Martinez Ibanez, V, Espanol, T, Matamoros, N. Relapse of sclerosing cholangitis after liver transplantation in patients with hyper-IgM syndrome. Transplant Proc 1997;29:432–3.CrossRefGoogle Scholar
Hadzic, N, Heaton, N D, Davies, G. Liver transplantation in children with primary immunodeficiencies [abstract]. Hepatology 1999;30:182A.Google Scholar
Horwitz, M E. Stem-cell transplantation for inherited immunodeficiency disorders. Pediatr Clin North Am 2000;47:1371–87.CrossRefGoogle ScholarPubMed
Thomas, C, Saint, B G, Deist, F. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. N Engl J Med 1995;333:426–9.CrossRefGoogle ScholarPubMed
Khawaja, K, Gennery, A R, Flood, T J. Bone marrow transplantation for CD40 ligand deficiency: a single centre experience. Arch Dis Child 2001;84:508–11.CrossRefGoogle ScholarPubMed
Amrolia, P, Gaspar, H B, Hassan, A. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000;96:1239–46.Google ScholarPubMed
Jacobsohn, D A, Emerick, K M, Scholl, P. Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin M syndrome with cholangiopathy. Pediatrics 2004;113:122–7.CrossRefGoogle ScholarPubMed
Boige, N, Bellaiche, M, Cornet, D. Hydrops-like cholecystitis due to cryptosporidiosis in an HIV-infected child. J Pediatr Gastroenterol Nutr 1998;26:219–21.CrossRefGoogle Scholar
Ramratnam, B, Flanigan, T P. Cryptosporidiosis in persons with HIV infection. Postgrad Med J 1997;73:713–16.CrossRefGoogle ScholarPubMed
Kahn, K, Sharp, H, Hunter, D, Kerzner, B. Primary sclerosing cholangitis in Wiskott–Aldrich syndrome. J Pediatr Gastroenterol Nutr 2001;32:95–9.CrossRefGoogle ScholarPubMed
Hicks, P, Zwiener, R J, Squires, J, Savell, V. Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus. J Pediatr 1997;130:1009–10.Google Scholar
Armitage, K, Flanigan, T, Carey, J. Treatment of cryptosporidiosis with paromomycin. A report of 5 cases. Arch Intern Med 1992;152:2497–9.CrossRefGoogle Scholar
Blanshard, C, Shanson, D C, Gazzard, B G. Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of Cryptosporidiosis. Int J Std AIDS 1997;8:124–9.CrossRefGoogle ScholarPubMed
Nachbaur, D, Kropshofer, G, Feichtinger, H. Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2. Bone Marrow Transplant 1997;19:1261–3.CrossRefGoogle ScholarPubMed
Rosignol, J F, Ayoub, A, Ayers, M S. Treatment of diarrhea caused by Cryptoporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001;184:103–6.CrossRefGoogle Scholar
Gilger, M A, Gann, M E, Opekun, A R, Gleason, WA Jr. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr 2000;31:136–41.CrossRefGoogle ScholarPubMed
Bollinger, M E, Arredongo-Vega, F X, Santisteban, I. Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency. N Engl J Med 1996;334:1367–71.CrossRefGoogle ScholarPubMed
Duval, M, Fenneteau, O, Doireau, V. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr 1999;134:236–9.CrossRefGoogle ScholarPubMed
Bader-Meunier, B, Parez, N, Muller, S. Treatment of hemophagocytic lymphohistiocytosis with cyclosporin A and steroids in a boy with lysinuric protein intolerance. J Pediatr 2000;136:134.CrossRefGoogle Scholar
Raby, R B, Ward, R B, Herrod, H G. Propionic academia and immunodeficiency. J Inher Metab Dis 1994;17:250–1.CrossRefGoogle Scholar
Al Essa, M, Rahbeeni, Z, Jumaah, S. Infectious complications of propionic academia in Saudi Arabia. Clin Genet 1998;54:90–4.CrossRefGoogle Scholar
Moreno, L A, Gottrand, F, Turck, D. Severe combined immunodeficiency syndrome associated with autosomal recessive familial multiple gastrointestinal atresias: study of a family. Am J Med Genet 1990;37:143–6.CrossRefGoogle ScholarPubMed
Walker, M W, Lovell, M A, Kelly, T E. Multiple areas of intestinal atresia associated with immunodeficiency and posttransfusion graft-versus-host disease. J Pediatr 1993;123:93–5.CrossRefGoogle ScholarPubMed
Gilroy, R K, Coccia, P F, Talmadge, J E. Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency. Blood 2004;103:1171–4.CrossRefGoogle ScholarPubMed
Fiore, M, Ammendola, R, Gaetaniello, L. Chronic unexplained liver disease in children with primary immunodeficiency syndromes. J Clin Gastroenterol 1998;26:187–92.CrossRefGoogle ScholarPubMed
Wittenberg, D, Benítez, C V, Canani, R B. HIV infection: working group report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004;39 Suppl 2:S640–6.CrossRefGoogle Scholar
Selik, R M, Lindegren, M L. Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999. Pediatr Infect Dis J 2003;22:635–41.CrossRefGoogle ScholarPubMed
Guarino, A, Bruzzese, E, Marco, G, Buccigrossi, V. Management of gastrointestinal disorders in children with HIV infection. Pediatr Drugs 2004;6:347–62.CrossRefGoogle ScholarPubMed
Fontana, M, Boldorini, R, Zuin, G. Ultrastructural changes in duodenal mucosa of HIV-infected children. J Pediatr Gastroenterol Nutr 1993;17:255–9.CrossRefGoogle ScholarPubMed
Duffy, L F, Daum, F, Kahn, E. Hepatitis in children with acquired immune deficiency syndrome: histopathologic and immunocytologic features. Gastroenterology 1986;90:173–81.CrossRefGoogle ScholarPubMed
Jonas, M M, Roldan, E O, Lyons, H J. Histopathologic features of the liver in pediatric acquired immune deficiency syndrome. J Pediatr Gastroenterol Nutr 1989;9:73–81.CrossRefGoogle ScholarPubMed
Viriyavejakul, P, Rojanasunan, P, Viriyavejakul, A. Opportunistic infections in the liver of HIV-infected patients in Thailand: a necropsy study. Southeast Asian J Trop Med Public Health 2000;31:663–7.Google ScholarPubMed
Gaur, S, Rosenthal, S, Dadhania, J. Cholestatic giant cell hepatitis associated with ultrastructural evidence of intrahepatic retroviral infection in a human immunodeficiency virus-seropositive infant. J Pediatr Gastroenterol Nutr 1993;16:199–202.CrossRefGoogle Scholar
Kahn, E, Greco, M A, Daum, F. Hepatic pathology in pediatric acquired immunodeficiency syndrome. Hum Pathol 1991;22:1111–19.CrossRefGoogle ScholarPubMed
Morotti, R A, Tata, M, Drut, R. Liver pathology in children with AIDS: a comparison between the South American and North American population. Pediatr Pathol Mol Med. 2001;20:537–45.Google ScholarPubMed
Lacaille, F, Fournet, J C, Blanche, S. Clinical utility of liver biopsy in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1999;18:143–7.CrossRefGoogle ScholarPubMed
Bouche, H, Housset, C, Dumont, J L. AIDS-related cholangitis: diagnostic features and course in 15 patients. J Hepatol 1993;17:34–9.CrossRefGoogle ScholarPubMed
Yabut, B, Werlin, S L, Havens, P. Endoscopic retrograde cholangiopancreatography in children with HIV infection. J Pediatr Gastroenterol Nutr 1996;23:624–7.CrossRefGoogle ScholarPubMed
Chung, C J, Sivit, C J, Rakusan, T A. Hepatobiliary abnormalities on sonography in children with HIV infection. J Ultrasound Med 1994;13:205–10.CrossRefGoogle ScholarPubMed
Cello, J P. Human immunodeficiency virus-associated biliary tract disease. Semin Liver Dis 1992;12:213–18.CrossRefGoogle ScholarPubMed
Lacaille, F, Ortigao, M B, Debre, M. Hepatic toxicity associated with 2′-3′dideoxy-inosine in children with AIDS. J Pediatr Gastroenterol Nutr 1995;20:287–90.CrossRefGoogle ScholarPubMed
Clark, S J, Creighton, S, Portmann, B., Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases. J Hepatol 2002;36:295–301.CrossRefGoogle ScholarPubMed
Scherpbier, H J, Hilhorst, M I, Kuijpers, T W. Liver failure in a child receiving highly active antiretroviral therapy and voriconazole. Clin Infect Dis 2003;37:828–30.CrossRefGoogle Scholar
Church, J A, Mitchell, W G, Gonzales-Gomes, I. Mitochondrial DNA depletion, near-fatal metabolic acidosis, and liver failure in an HIV-infected child treated with combination antiretroviral therapy. J Pediatr 2001;138:748–51.CrossRefGoogle Scholar
Asuncion, J G, del Olmo, M L, Sastre, J, Pallardo, F V, Vina, J. Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver. Hepatology 1999;29:985–7.CrossRefGoogle ScholarPubMed
Prachalias, A A, Pozniak, A, Taylor, C. Liver transplantation in adults coinfected with HIV. Transplantation 2001;72:1684–8.CrossRefGoogle Scholar
Neff, G W. Bonham, A, Tzakis, A G. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transplant 2003;9:239–47.CrossRefGoogle ScholarPubMed
Martin, P, DiBisceglie, A M, Kassianides, C. Rapidly progressive non-A non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989;97:1559–61.CrossRefGoogle ScholarPubMed
Housset, C, Pol, S, Carnot, F. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology 1992;15:578–83.CrossRefGoogle ScholarPubMed
Resti, M, Azzari, C, Bortolotti, F. Hepatitis C virus infection in children coinfected with HIV: epidemiology and management. Pediatr Drugs 2002;4:571–80.CrossRefGoogle ScholarPubMed
Strader, D B, Wright, T, Thomas, T L, Seeff, L B. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147–71.CrossRefGoogle ScholarPubMed
Puoti, M, Torti, C, Bruno, R. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006;44:S65–70.CrossRefGoogle ScholarPubMed
Benhamou, Y. Treatment algorithm for chronic hepatitis B in HIV-infected patients. J Hepatol 2006;44:S90–4.CrossRefGoogle ScholarPubMed
Lau, G, Suri, D, Liang, R. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 2002;122:614–24.CrossRefGoogle ScholarPubMed
Quinti, I, Pandolfi, F, Paganelli, R. HCV infection in patients with primary defects of immunoglobulin production. Clin Exp Immunol 1995;102:11–16.CrossRefGoogle ScholarPubMed
Christie, J M, Healey, C J, Watson, J. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Clin Exp Immunol 1997;110:4–8.CrossRefGoogle ScholarPubMed
Sumazaki, R, Matsubara, T, Aoki, T. Rapidly progressive hepatitis C in a patient with common variable immunodeficiency. Eur J Pediatr 1996;155:532–4.CrossRefGoogle Scholar
Watson, J P, Bewitt, D J, Spickett, G P. Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients. J Hepatol 1996;25:599–607.CrossRefGoogle ScholarPubMed
Bjoro, K, Froland, S S, Yun, Z. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607–11.CrossRefGoogle ScholarPubMed
Yap, P L, McOmish, F, Webster, A D B. Hepatitis C virus transmission by intravenous immunoglobulin. J Hepatol 1994;21:455–60.CrossRefGoogle ScholarPubMed
Smith, M S H, Webster, D B, Dhillon, A P. Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency. Gastroenterology 1995;108:879–84.CrossRefGoogle ScholarPubMed
Gow, P J, Mutimer, D. Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency. Transplant Int 2002;15:380–3.CrossRefGoogle Scholar
Janka, G E, Schneider, E M. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Hematol 2004;124:4–14.CrossRefGoogle ScholarPubMed
Hirst, W J, Layton, D M, Singh, S. Haemophagocytic lymphohistiocytosis: experience at two U.K. centres. Br J Hematol 1994;88:731–9.CrossRefGoogle ScholarPubMed
Farquhar, J W, Claireaux, A E. Familial haemophagocytic reticulosis. Arch Dis Child 1952;27:519–25.CrossRefGoogle ScholarPubMed
Arico, M, Danesino, C, Pende, D, Moretta, L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Hematol 2001;114:761–9.CrossRefGoogle ScholarPubMed
Henter, J I, Samuelsson-Horne, Arico, M. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002;100:2367–73.CrossRefGoogle ScholarPubMed
Menasche, G, Feldmann, J, Fischer, A, Saint Basile, G. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev 2005;203:165–79.CrossRefGoogle ScholarPubMed
Chisuwa, H, Hashikura, Y, Nakazawa, Y. Fatal hemophagocytic syndrome after living-related liver transplantation: a report of two cases. Transplantation 2001;72:1843–6.CrossRefGoogle ScholarPubMed
Ohadi, M, Lalloz, M R, Sham, P. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3–22 by homozygosity mapping. Am J Hum Genet 1999;64:165–71.CrossRefGoogle ScholarPubMed
Dufourcq-Lagelouse, R, Jabado, N, Deist, F. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21–22 and evidence for heterogeneity. Am J Hum Genet 1999;64:172–9.CrossRefGoogle ScholarPubMed
Feldmann, J, Callebaut, I, Raposo, G. Munc13–4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003;115:461–73.CrossRefGoogle Scholar
zur Stadt, U, Schmidt, S, Kasper, B. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Gen 2005;14:827–34.CrossRefGoogle ScholarPubMed
Stepp, S E, Dufourcq-Lagelouse, R, Deist, F. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999;286:1957–9.CrossRefGoogle ScholarPubMed
Kogawa, K, Lee, S M, Villanueva, J. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 2002;99:61–6.CrossRefGoogle ScholarPubMed
McClain, K, Gehrz, R, Grierson, H. Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies. Am J Pediatr Hematol Oncol 1988;10:196–205.CrossRefGoogle ScholarPubMed
Stephan, J L, Donadieu, J, Ledeist, F. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 1993;82:2319–23.Google ScholarPubMed
Fischer, A, Cerf-Bensussan, N, Blanche, S. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr 1986;108:267–70.CrossRefGoogle ScholarPubMed
Durken, M, Horstmann, M, Bieling, P. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients. Br J Hematol 1999;106:1052–8.CrossRefGoogle ScholarPubMed
Horne, A, Janka, G, Maarten Egeler, R. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Hematol 2005;129:622–30.CrossRefGoogle ScholarPubMed
Cooper, N, Rao, K, Gilmour, K. Stem cell transplantation with reduced intensity conditioning for haemophagocytic lymphohistiocytosis. Blood 2006;107:1233–6.CrossRefGoogle Scholar
Matthes-Martin, S, Peters, C, Koningsrainer, A. Successful stem cell transplantation following liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood 2000;96:3997–9.Google Scholar
Purtilo, D T, Cassel, C K, Yang, J P S. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975;i:935–41.CrossRefGoogle Scholar
Bar, R S. DeLor CJ, Clausen KP, et al. Fatal infectious mononucleosis in a family. N Engl J Med 1974;290:363–7.CrossRefGoogle ScholarPubMed
Howie, D, Sayos, J, Terhorst, C, Morra, M. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus. Curr Opin Immunol 2000;12:474–8.CrossRefGoogle ScholarPubMed
Sullivan, J L, Byron, K S, Brewster, F E. X-linked lymphoproliferative syndrome: natural history of the immunodeficiency. J Clin Invest 1983;71:1765–8.CrossRefGoogle ScholarPubMed
Nichols, K E, Ma, C S, Cannons, J L. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev 2005;203:180–99.CrossRefGoogle ScholarPubMed
Sayos, J, Wu, C, Morra, M. The X linked lymphoproliferative–disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998;395:462–9.CrossRefGoogle ScholarPubMed
Sharifi, R, Sinclair, J C, Gilmour, K C. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood 2004;103:3821–7.CrossRefGoogle ScholarPubMed
Skare, J C, Sullivan, J L, Milunsky, A. Mapping the mutation causing the X-linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq. Hum Genet 1989;82:349–53.CrossRefGoogle ScholarPubMed
Pinkerton, C R, Hann, I, Weston, C L. Immunodeficiency-related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry. Br J Hematol 2002;118:456–61.CrossRefGoogle ScholarPubMed
Gross, T G, Filipovich, A H, Conley, M E. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996;17:741–4.Google ScholarPubMed
Finn, A, Hadzic, Morgan, G, Strobel, S, Levinsky, R J. Prognosis of chronic granulomatous disease. Arch Dis Child 1990;65:942–5.CrossRefGoogle ScholarPubMed
Muorah, M, Hinds, R, Verma, A. Liver abscesses in children in the developed world: a single centre experience. J Pediatr Gastroenterol Nutr 2006;42:201–6.CrossRefGoogle Scholar
Bylund, J, Goldblatt, D, Speert, D P. Chronic granulomatous disease: from genetic defect to clinical presentation. Adv Exp Med Biol 2005;568:67–87.CrossRefGoogle ScholarPubMed
Gungor, T, Halter, J, Klink, A. Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation 2005;79:1596–606.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Liver Disease in Immunodeficiencies
    • By Nedim Hadžić, M.D., Senior Lecturer, Institute for Liver Studies, King's College London School of Medicine at King's College Hospital, London, England; Consultant in Paediatric Hepatology, Department of Children's Health, King's College Hospital, London, England
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.023
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Liver Disease in Immunodeficiencies
    • By Nedim Hadžić, M.D., Senior Lecturer, Institute for Liver Studies, King's College London School of Medicine at King's College Hospital, London, England; Consultant in Paediatric Hepatology, Department of Children's Health, King's College Hospital, London, England
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.023
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Liver Disease in Immunodeficiencies
    • By Nedim Hadžić, M.D., Senior Lecturer, Institute for Liver Studies, King's College London School of Medicine at King's College Hospital, London, England; Consultant in Paediatric Hepatology, Department of Children's Health, King's College Hospital, London, England
  • Edited by Frederick J. Suchy, Mount Sinai School of Medicine, New York, Ronald J. Sokol, University of Colorado, Denver, William F. Balistreri, University of Cincinnati
  • Book: Liver Disease in Children
  • Online publication: 18 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547409.023
Available formats
×